🇺🇸 FDA
Patent

US 8435570

Nitrite formulations and their use as nitric oxide prodrugs

granted A61KA61K31/195A61K31/375

Quick answer

US patent 8435570 (Nitrite formulations and their use as nitric oxide prodrugs) held by The Board of Regents of the University of Texas System expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/195, A61K31/375, A61K33/00